Belvedere Trading LLC Recursion Pharmaceuticals, Inc. Call Options Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Oct 27, 2023
BUY
$6.59 - $15.86 $50,084 - $120,536
7,600 New
7,600 $58,000
Q4 2021

Jan 25, 2022
SELL
$16.14 - $21.86 $185,610 - $251,390
-11,500 Closed
0 $0
Q3 2021

Oct 19, 2021
SELL
$19.03 - $41.33 $39,963 - $86,793
-2,100 Reduced 15.44%
11,500 $222,000
Q2 2021

Jul 23, 2021
BUY
$18.0 - $37.42 $244,800 - $508,912
13,600 New
13,600 $475,000

Others Institutions Holding RXRX

# of Institutions
295
Shares Held
242M
Call Options Held
1.35M
Put Options Held
2.32M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.27B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email